Review article · 2021 · Open access
Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)
Experimental and Therapeutic Medicine, 21(3), 276 · Published 25 January 2021 · DOI 10.3892/etm.2021.9707
In brief
“Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)” is a 2021 review article by Octavia Căpățînă and 2 co-authors, published in Experimental and Therapeutic Medicine. OpenAlex counts 28 citations as of 20 November 2026, which puts it in the top 7% of works published in 2021 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Experimental and Therapeutic Medicine.
- Citations
- 28
- Most cited in
- 2022 (7)
- Field-weighted impact
- 0.76
- References
- 68
- Authors
- 3
Abstract
The negative symptoms of schizophrenia are an unmet treatment target as currently approved treatments mostly control positive symptoms. The persistence of these symptoms holds back the patient's reinstatement in society, making them incapable of fulfilling their social, professional, or family roles. There is overwhelming research evidence suggesting that the negative symptoms of schizophrenia are associated with poorer functioning and lower quality of life than positive symptoms, confirming the need for developing new treatments for this particular category of symptoms. This present review aims to review clinical trials addressing novel pharmacological approaches addressing primary negative symptoms of schizophrenia. We overview both monotherapies, first-generation and second-generation antipsychotics, and add-on therapies, including psychostimulants, anti-inflammatory drugs, antidepressants, molecules targeting glutamatergic, cholinergic or serotonergic systems and hormones. Our findings suggest that the primary negative symptoms of schizophrenia may be mitigated by adjunctive therapies, and we highlight the pharmacological agents that have proven superior efficacy. Novel compounds such as cariprazine and MIN-101, to date, show promising results, but large clinical trials are needed to test their efficacy and safety.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Căpățînă, O., Micluția, I., & Stănculete, M. F. (2021). Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review). Experimental and Therapeutic Medicine, 21(3), 276. https://doi.org/10.3892/etm.2021.9707
MLA 9
Căpățînă, Octavia, et al. “Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review).” Experimental and Therapeutic Medicine, vol. 21, no. 3, 2021, p. 276. https://doi.org/10.3892/etm.2021.9707.
Chicago
Căpățînă, Octavia, I. Micluția, and Mihaela Fadgyas Stănculete. 2021. “Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review).” Experimental and Therapeutic Medicine 21 (3): 276. https://doi.org/10.3892/etm.2021.9707.
Harvard
Căpățînă, O., Micluția, I. and Stănculete, M. F. (2021) ‘Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)’, Experimental and Therapeutic Medicine, 21(3), p. 276. doi:10.3892/etm.2021.9707.
IEEE
O. Căpățînă, I. Micluția, and M. F. Stănculete, “Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review),” Experimental and Therapeutic Medicine, vol. 21, no. 3, p. 276, 2021, doi: 10.3892/etm.2021.9707.
BibTeX
@article{capatina2021current,
title = {{Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)}},
author = {Căpățînă, Octavia and Micluția, I. and Stănculete, Mihaela Fadgyas},
journal = {Experimental and Therapeutic Medicine},
year = {2021},
volume = {21},
number = {3},
pages = {276},
doi = {10.3892/etm.2021.9707},
url = {https://doi.org/10.3892/etm.2021.9707}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 6 | |
| 2022 | 7 | |
| 2023 | 5 | |
| 2024 | 5 | |
| 2025 | 3 | |
| 2026 | 2 |
Its field-weighted citation impact is 0.76: it has been cited 0.76 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- schizophrenia
- negative symptoms
- pharmacotherapy
- adjunctive therapy
- typical antipsychotics
- atypical antipsychotics
- psychostimulants
- anti-inflammatory agents
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Căpățînă, O., Micluția, I., & Stănculete, M. F. (2021). Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review). Experimental and Therapeutic Medicine, 21(3), 276. https://doi.org/10.3892/etm.2021.9707
How many times has this paper been cited?
28 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Experimental and Therapeutic Medicine: sign in and open the PDF from this page.
Who wrote this paper?
Octavia Căpățînă, I. Micluția, Mihaela Fadgyas Stănculete.
What is the DOI of this paper?
10.3892/etm.2021.9707, permanently at https://doi.org/10.3892/etm.2021.9707. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.